Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Saw you posting over on Nwg. Probably see a drop next week after the Divi reinvestment but nice to get a few back after the consolidation. As for Oxb it never ceases to amaze….a few stop losses hit this morning. They are going to need a few large contracts to stop the rot. As for selling and cutting ones losses it’s always a hard decision and with its volatility it could be £5.00 next week.. Vulpes must be down a fortune.
im going to wait a bit longer before buying in.. really disappointed at todays news, but maybe come back next year and see where it is.
id been looking at this one for ages as well... but sell and lease back... always worries me.
imo.. near miss for me..
Sale and leaseback isn't death spiral financing but it's hardly a sign of strength either and that's the way the market seems to have taken it reading the interims as no likelihood of profitability soon and cashflow problems.
In an acute dilemma as to whether to crystallise my large losses or hang on for a few more years, as that's as long as it's going to be imho
Spoke too soon about the mid £4’s
The sale and leaseback is an expensive way of doing business long term.How much of the loan is going to be repaid? Another few years before it’s profitable by the looks of it but isn’t it always…the covid vaccine has been its saviour. As you say the market isn’t impressed. The mid £4’s seems to be where the sp is at the moment . The big investors are locked in for years to come but tomorrows another a day.
Hasn't caused any excitement in the market. Hard to know what to make of them despite the upbeat commentary though at least we are now clear that the AZ bonanza is over. In my (admittedly limited) experience - sale and leaseback is usually a method of raising capital at the expense of ongoing commitments so what does it mean here?
There appears to be a long way to go yet before it becomes profitable.
All my biotechs are suffering - Angle, SAR, VAL - and this is no exception.
I hope so though the previous appear to have done nothing for us; as the rns says "with this being the fifth new or expanded customer partnership we have announced this year" and look what has happened to the sp.
Still holding but probably more in hope than expectation. Will make a decision after the interims to stick or twist.
GLALTH
The "undisclosed" sum may be irrelevant BUT the "undisclosed" customer is - i would interpret this as a potential break through of course with its risk attached
Yes which means we have no idea of the significance of this - is it substantial or peanuts - so it doesn't help shift the sp as we can see from the reaction.
Hopefully the interim will at least bring some clarity to the financial situation and be a bit forward looking but who knows.
Oxb love the word “ undisclosed.”
there are only 83 small transactions, are they relevant ?
May 2018 was the 1 for 50 consolidation. Who would have thought after reaching the dizzying heights of £16 or thereabouts Oxb has lost 75% of its value. Would love to know what money is left in the bank. Not long to wait now. You have to ask yourself going forward what is going to impress the market? Homology is very quiet. GL all.
Hi Shatter
Good to know you are keeping an eye on us poor souls!
Interim in 3 weeks so some answers might emerge. This is what was said in April. Will we be as positive in September?
Total revenues increased by 63% over 2020 to £142.8 million (2020: £87.7 million).
· Revenues from bioprocessing and commercial development continued its upward trend, growing 87% due to large scale commercial manufacture of the Oxford AstraZeneca COVID-19 vaccine.
· Operating EBITDA1 and operating profits improved by £28.5 million and £26.5 million respectively, with the Group generating an Operating EBITDA1 profit of £35.9 million and an operating profit of £20.8 million.
Hi Kern. Oxb still as volatile as ever. Large swings for seemingly no reason. Did look at it this morning when it was in the 430’s and considered a small punt but it’s just to difficult to read. I wonder how the finances are?
We will be lucky to stay above £4 at this rate. Very difficult to see what might turn this around.
Sounds good but must mean that it isn't being used for AZ vaccines.
Lets hope we can stay above £5 and build from there.
GLALTH
I found this little snippet of news on Business Standard
"Serum Institute of India may use Oxford Biomedica's plant to make malaria, flu vaccines
Plans to utilise the UK capacity over the 10-year tie-up"
@ shatter - quite agree about Peel Hunt; don't need to change too many letters to get what I think of them too :)
jamieboy2 Good for you that your wrote the only post and you left GL to you and don't come back
What you say is fixable, they demonstrate scalable production and it is the perfect target for take over to improve the management
as someone who has recently left OXB i can inform you that they do not own OXBOX, it was leased and neither do they own ISIS house next to Windrush. In addition as key staff leave they are not being replaced and the moral of the staff is very low nd a large amount of the staff are looking to leave. The staff have no faith in the management and it is only going one way ane that is down.
Yep. Another false dawn. Still in but wishing I wasn't.
GLALTH
Can't seem to stay above a fiver for any length of time
Is this the start of something or another false dawn?
And yes something needs to be done about the dismal share price but not sure what?
I never rated Peel Hunt but another broker might possibly be an indication of a listing across the water!